Close Menu

The Washington Post tells the story of an Army medic and his father who took direct-to-consumer genetic test as a means of looking into the DTC industry. The Galls had their DNA looked at by both 23andMe and Decode and Timothy Gall, the medic, says that he found some of the results useful — such as a potential sensitivity to blood thinners — but others were baffling.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.